Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis
This study has been terminated.
(Enrollment terminated pending additional Phase 1 data)
First Posted: December 16, 2010
Last Update Posted: July 18, 2014
Information provided by (Responsible Party):
Celgene ( Celgene Corporation )